Amerise Biosciences Limited (BOM:531681)

Amerise Biosciences Revenue

In the fiscal year ending March 31, 2026, Amerise Biosciences had annual revenue of 2.55M INR with 35.74% growth. Amerise Biosciences had revenue of 792.00K in the quarter ending March 31, 2026, a decrease of -57.87%.

• Revenue: 2.55M
• Revenue Growth: +35.74%
• P/S Ratio: 19.16
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 48.89M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.55M	672.00K	35.74%
Mar 31, 2025	1.88M	1.52M	423.68%
Mar 31, 2024	359.00K	271.00K	307.95%
Mar 31, 2023	88.00K	-95.69M	-99.91%
Mar 31, 2022	95.77M	97.46M	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 7, 2026

Data Sources Report a data error